Does Dupixent’s patent expire in 2031?
Dupixent (dupilumab) has multiple patents and exclusivity protections, so “the” expiration date depends on the specific patent family and country. Patents are not a single end date; different claims can expire at different times, including earlier expiries in some jurisdictions and later ones in others.
With only the information provided in this chat, I can’t verify a specific “2031” expiration for Dupixent. If you share the country (e.g., US, EU, UK, Canada) or a patent number/link you’re looking at, I can help interpret what that document actually covers and whether 2031 is a likely date for that particular protection.
What usually determines whether Dupixent is still protected in 2031?
Even when marketing authorization is long past, drug availability can stay limited due to a mix of:
- Patent expiry for specific claims (often differs by jurisdiction)
- Regulatory exclusivity (which can extend beyond initial patent term)
- Extensions or adjustments attached to manufacturing/marketing timelines (where applicable)
Because all of these can differ by country and by the particular patent family, a year like 2031 is only meaningful when tied to a specific patent/exclusivity right.
How can you check the “right” Dupixent expiration date for your country?
To confirm whether a given date like 2031 applies, the key is matching:
- Jurisdiction (US vs EU vs other)
- Product (dupilumab/Dupixent)
- Route/formulation (if relevant to the patent)
- Exact protection type (primary patent vs secondary formulation/use vs regulatory exclusivity)
- The specific patent document the date comes from
Common practical sources include national patent registers and regulators’ exclusivity/patent linkage tools (for the US, this is often done through FDA patent listings tied to Orange Book–style information).
Could biosimilars enter before (or after) a 2031 date?
Yes, in many systems biosimilars can seek approval before the reference product’s last patent/exclusivity expires, but launch is often blocked until relevant protections end or are cleared in court. The timing depends on which specific patents are still in force and whether there’s litigation or settlement.
If someone says “2031,” what should you verify?
If you’re seeing “2031” cited online, verify at least:
- The country the date refers to
- The specific patent number or exclusivity type
- Whether the date is for “last patent expires” or “last regulatory exclusivity ends”
- Whether there are ongoing challenges or amendments that change the practical end date
If you paste the link, patent number, or jurisdiction you’re referencing, I can help you determine whether “2031” is the most relevant expiration date and what exactly would still block competition after that point.
Sources
No sources were provided in the prompt, so I can’t cite any claims about a 2031 Dupixent expiration date.